If you have a certain kind of cancer or tumor, your doctor may prescribe Xgeva to help prevent serious bone problems. Xgeva is a prescription drug that’s used in adults to: Doctors may also prescribe ...

AVT03 is a proposed biosimilar to Amgen's Prolia and Xgeva and has been developed by Alvotech hf. According to the company, ...

Xgeva (denosumab) is a prescription drug that’s used to treat bone problems caused by certain cancers or tumors. Xgeva can cause side effects that range from mild to serious. Examples include jaw and ...

Approvals expand Amneal’s biosimilars portfolioCompany expects to commercialize six biosimilars across eight presentations by 2027BRIDGEWATER, ...

Xgeva (denosumab) is a brand-name solution for subcutaneous injection that’s prescribed for certain bone conditions. The cost of the drug, with and without insurance, can depend on several factors. As ...

"We now finally have evidence that bone-targeted treatment is not only successful in treating bony metastases and preventing treatment-induced bone loss," said Michael Gnant. A follow-up analysis of ...

A breast cancer diagnosis is devastating. To hear that it has metastasized takes that devastation to another level. Amgen’s “Moments that Matter” campaign for bone metastases drug, Xgeva (denosumab), ...

While the primary endpoint of the study is Xgeva’s safety profile, secondary endpoints include time to disease progression and the proportion of patients without any surgery at six months. Amgen said ...

US regulators have expanded the scope of Amgen’s Xgeva to include the prevention of skeletal-related events in patients with multiple myeloma. US regulators have expanded the scope of Amgen’s Xgeva to ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today positive top-line results from a ...

Amgen (Nasdaq: AMGN) today announced top-line results from a Phase 3 trial evaluating XGEVA(TM) (denosumab) versus placebo in 1,432 men with castrate-resistant prostate cancer. The trial, known as the ...

These are just a few of the more common side effects reported by people who received Xgeva in clinical trials. These side effects can vary, depending on the condition that the drug is being used to ...